Silvia, Patient and SSO Board Member

How COVID-19 has affected Silvia.

Recent Posts

Employment Outcomes in Systemic Sclerosis

(FR) La Scléromyosite - Une nouvelle frontière (EN) Scleromyositis - A New Frontier

Mallinckrodt Pharmaceuticals: June is Scleroderma Awareness Month